Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.923,46
-0,03%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Evofem Biosciences Inc (EVFM) Evofem Biosciences Inc (EVFM) Notizie

EVFM

Evofem Biosciences (EVFM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:EVFM
DataOraFonteTitoloSimboloCompagnia
16/06/202323:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EVFMEvofem Biosciences Inc
16/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
01/06/202314:36PR Newswire (US)Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023NASDAQ:EVFMEvofem Biosciences Inc
17/05/202322:50PR Newswire (US)Evofem Biosciences Announces 1-for-125 Reverse Stock SplitNASDAQ:EVFMEvofem Biosciences Inc
12/05/202322:16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EVFMEvofem Biosciences Inc
27/04/202323:29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EVFMEvofem Biosciences Inc
12/04/202314:48PR Newswire (US)Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization RequiredNASDAQ:EVFMEvofem Biosciences Inc
12/04/202312:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:EVFMEvofem Biosciences Inc
31/03/202322:03Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:EVFMEvofem Biosciences Inc
21/03/202313:48PR Newswire (US)Evofem Biosciences Announces Cost Reduction MeasuresNASDAQ:EVFMEvofem Biosciences Inc
09/03/202312:50PR Newswire (US)Evofem Biosciences Appoints Interim Chief Financial OfficerNASDAQ:EVFMEvofem Biosciences Inc
06/03/202320:49Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:EVFMEvofem Biosciences Inc
28/02/202314:48PR Newswire (US)Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product OfferingNASDAQ:EVFMEvofem Biosciences Inc
27/02/202313:46PR Newswire (US)Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for PhexxiNASDAQ:EVFMEvofem Biosciences Inc
23/02/202314:34PR Newswire (US)Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder ValueNASDAQ:EVFMEvofem Biosciences Inc
15/02/202322:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EVFMEvofem Biosciences Inc
27/01/202312:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:EVFMEvofem Biosciences Inc
10/01/202314:36PR Newswire (US)Costco Adds Phexxi® to Member Prescription ProgramNASDAQ:EVFMEvofem Biosciences Inc
09/01/202314:54PR Newswire (US)Multiple New Insurance Wins Expand and Improve Access to Phexxi® for Millions of WomenNASDAQ:EVFMEvofem Biosciences Inc
03/10/202212:49Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EVFMEvofem Biosciences Inc
30/09/202222:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EVFMEvofem Biosciences Inc
23/09/202223:06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:EVFMEvofem Biosciences Inc
11/08/202202:23PR Newswire (US)Evofem Biosciences to Host Investor Call on Thursday, August 11, 2022NASDAQ:EVFMEvofem Biosciences Inc
10/08/202222:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EVFMEvofem Biosciences Inc
04/08/202222:01PR Newswire (US)Evofem Biosciences Announces Strong Second Quarter 2022 Financial Results and Affirms 2022 GuidanceNASDAQ:EVFMEvofem Biosciences Inc
03/08/202214:24PR Newswire (US)Evofem Biosciences Strengthens Board of DirectorsNASDAQ:EVFMEvofem Biosciences Inc
01/08/202214:47PR Newswire (US)Evofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 "EVOGUARD" Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in WomenNASDAQ:EVFMEvofem Biosciences Inc
29/07/202214:24PR Newswire (US)Evofem Biosciences Commends Tri-Agencies for Clarifying that Contraceptives Must be Covered at No Cost to IndividualsNASDAQ:EVFMEvofem Biosciences Inc
28/07/202214:47PR Newswire (US)Evofem Biosciences to Report Second Quarter 2022 Results and Provide Corporate Update on Thursday, August 4, 2022NASDAQ:EVFMEvofem Biosciences Inc
26/07/202214:47PR Newswire (US)Evofem's House Rules Campaign Featuring Annie Murphy Receives Significant Industry RecognitionNASDAQ:EVFMEvofem Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:EVFM

La tua Cronologia

BIT
HPAJ
Exchange Traded
COIN
GENDGBP
Legendary Coin
UNSW3
BFCETH
Bifrost
LATK
ATLASUSDT
Star Atlas
EU
WZ99B
WZ99B
ASX
BOQIYE
NASDAQ
CCSIV
Concsnsus Cloud Solutions
USOTC
MFGCF
Mayfair Gold (QX)
EU
B297S
B297S
UNSW
VIETH
Vybit
USOTC
MSSEL
Massachusetts Electric (CE)
COIN
XENUSD
XEN Crypto
AMEX
WNF.U
HITB
WIZBTC
CrowdWizToken
BOV
N1EM34
Newmont
COIN
MYTHHUSD
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network